What data powers the Rallies AI report for BDRX?

Rallies AI research for BDRX combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.

Is BDRX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BDRX. It does not provide personalized investment advice.

BDRX (Biodexa Pharmaceuticals plc American Depositary Shs) Stock Analysis - AI Report

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) is a publicly traded Healthcare sector company. As of May 21, 2026, BDRX trades at $3.11 with a market cap of $2.04M and a P/E ratio of 0.00. BDRX moved +0.00% today. Year to date, BDRX is -75.22%; over the trailing twelve months it is -95.29%. Its 52-week range spans $2.86 to $544.50. Rallies surfaces BDRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on BDRX?

Rallies AI research for BDRX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

BDRX Key Metrics

Key financial metrics for BDRX
Metric	Value
Price	$3.11
Market Cap	$2.04M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$544.50
52-Week Low	$2.86
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Latest BDRX News

Biodexa Plans 1-for-10,000 Reverse Split Creating 373 Billion E Deferred Shares, Resets ADS Ratio — May 14, 2026
Biodexa In-licenses MTX240, Secures Oral Rapamycin Patent and Advances Phase 3 eRapa Enrollments — Mar 27, 2026
Biodexa Launches Global eRapa Access Program, Prepping Phase 3 Trial Backed by $20 M Grant — Mar 23, 2026
Biodexa Implements 1-for-5 Reverse ADR Split to Comply with Nasdaq $1 Rule — Mar 18, 2026
Biodexa Secures MTX240 Licensing for TKI-Resistant GIST with 2037 Patent Protection — Feb 19, 2026

BDRX Analyst Consensus

BDRX analyst coverage data. Average price target: $0.00.

Common questions about BDRX

What is the AI research view on BDRX?: Rallies AI research for BDRX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for BDRX?: Rallies AI research for BDRX combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is BDRX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BDRX. It does not provide personalized investment advice.